SignatureFD’s Axonics, Inc. Common Stock AXNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-203
| Closed | -$14.1K | – | 3439 |
|
|
2024
Q3 | $14.1K | Hold |
203
| – | – | ﹤0.01% | 2205 |
|
|
2024
Q2 | $13.6K | Sell |
203
-28
| -12% | -$1.89K | ﹤0.01% | 2141 |
|
|
2024
Q1 | $15.9K | Hold |
231
| – | – | ﹤0.01% | 2106 |
|
|
2023
Q4 | $14.4K | Sell |
231
-58
| -20% | -$3.25K | ﹤0.01% | 2089 |
|
|
2023
Q3 | $16.2K | Buy |
289
+87
| +43% | +$4.89K | ﹤0.01% | 1960 |
|
|
2023
Q2 | $10.2K | Sell |
202
-189
| -48% | -$10.1K | ﹤0.01% | 2226 |
|
|
2023
Q1 | $21.3K | Sell |
391
-272
| -41% | -$15.9K | ﹤0.01% | 1836 |
|
|
2022
Q4 | $41.5K | Buy |
663
+138
| +26% | +$9.16K | ﹤0.01% | 1452 |
|
|
2022
Q3 | $37K | Buy |
525
+13
| +3% | +$897 | ﹤0.01% | 1440 |
|
|
2022
Q2 | $29K | Buy |
512
+61
| +14% | +$3.34K | ﹤0.01% | 1598 |
|
|
2022
Q1 | $28K | Buy |
451
+361
| +401% | +$19.5K | ﹤0.01% | 1677 |
|
|
2021
Q4 | $5K | Buy |
90
+5
| +6% | +$306 | ﹤0.01% | 2442 |
|
|
2021
Q3 | $6K | Buy |
85
+10
| +13% | +$682 | ﹤0.01% | 2315 |
|
|
2021
Q2 | $5K | Buy |
75
+8
| +12% | +$472 | ﹤0.01% | 2314 |
|
|
2021
Q1 | $4K | Buy |
67
+19
| +40% | +$1.03K | ﹤0.01% | 2285 |
|
|
2020
Q4 | $2K | Sell |
48
-18
| -27% | -$845 | ﹤0.01% | 2335 |
|
|
2020
Q3 | $3K | Buy |
+66
| New | +$2.75K | ﹤0.01% | 2145 |
|
Other funds holding AXNX
SignatureFD's AXNX Position: Q4 2024 in Review
SignatureFD sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 203 shares — an estimated $14.1K sold.
SignatureFD first reported a position in AXNX in Q3 2020 and held it in 17 quarters. The position peaked at $41.5K in Q4 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.
- SignatureFD reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- SignatureFD sold 203 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $14.1K.
- SignatureFD first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 17 quarters.
- SignatureFD's Axonics, Inc. Common Stock position peaked at $41.5K in Q4 2022.
- 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.
Based on SignatureFD's 13F filing for Q4 2024, filed 10 Feb 2025.